Parameter		Univariate analysis			Multivariate analysis
		HR	95% CI	p	HR	95% CI	p
OS	Chemotherapy vs Haplo-HSCT	2.447	1.532–3.908	p<0.001	1.958	1.211–3.163	p = 0.006
	Age > 40 vs <40	2.344	1.492–3.683	p<0.001	1.712	1.034–2.836	p = 0.037
	Cytogenetic Other vs Normal	2.091	1.296–3.373	p = 0.002	1.858	1.100–3.136	p = 0.02
DFS	Chemotherapy vs Haplo-HSCT	2.595	1.657–4.064	p<0.001	2.529	1.612–3.965	p<0.001
	Cytogenetic Other vs Normal	1.802	1.133–2.865	p = 0.013	1.688	1.06–2.688	p = 0.027
Relapse	Chemotherapy vs Haplo-HSCT	9.399	4.26–20.737	p<0.001	9.399	4.26–20.737	p<0.001
TRM	Chemotherapy vs Haplo-HSCT	0.321	0.136–0.756	p = 0.009	0.300	0.127–0.709	p = 0.006
	Cytogenetic Other vs Normal	2.596	1.193–5.651	p = 0.016	2.840	1.304–6.185	p = 0.009